Pancreatic Cancer Research

ResearcherYamaguchi UniversityActive in the last 2 years

Katsuyoshi Ito

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1483-0369; OpenAlex author ID A5072909990. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). Co-author DOI 10.1097/mpa.0000000000002323↗
  2. Impact on the image quality of modified reduced field-of-view diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinoma using spatially tailor… Last author DOI 10.1016/j.ejrad.2023.111138↗
  3. [Five Cases of Ten-Year Survival after Surgical Treatment of Pancreatic Cancer in Yamaguchi Prefecture]. Co-author PMID 32156955↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoshitaro Shindo · 2 shared papers, 2019–2024 · strength 0.25
  2. Hiroaki Nagano · 2 shared papers, 2019–2024 · strength 0.25
  3. Kimikazu Hamano · 2 shared papers, 2019–2024 · strength 0.25
  4. Hiroto Matsui Matsui · 2 shared papers, 2019–2024 · strength 0.25
  5. Masahiro Tanabe · 2 shared papers, 2019–2023 · strength 0.25
  6. Tatsuya Ioka · 1 shared paper, 2024 · strength 0.17
  7. Masao Nakajima · 1 shared paper, 2024 · strength 0.17
  8. Taro Takami · 1 shared paper, 2024 · strength 0.17
  9. Hidekazu Tanaka · 1 shared paper, 2024 · strength 0.17
  10. Mototsugu Shimokawa · 1 shared paper, 2023 · strength 0.17
  11. Tomio Ueno · 1 shared paper, 2019 · strength 0.08
  12. Yasuhiro Fujiwara · 1 shared paper, 2019 · strength 0.08
  13. Isao Sakaida · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.